News FDA Clears First Drug for Neurotrophic Keratitis by Medscape • 2018/08/23 • 0 Comments Cenegermin eye drops (Oxervate) are a recombinant form of human nerve growth factor that stimulate growth and survival of corneal epithelial cells. FDA Approvals Full Story →